Retatrutide (RT5)|99%+ High Purity Peptide Powder | 5 mg/vial | CAS 2381089-83-2 | For Obesity & Type 2 Diabetes | Weight Loss, Fat Burning, Blood S

Sales manager:  Eira
whatsapp：+8619304441463
Email:  sales01@cnspks.com

For Individual Buyers

Looking for the most advanced weight management peptide available? Retatrutide (RT5) represents the latest generation of metabolic research. Unlike single or dual-agonist peptides, Retatrutide works through three distinct pathways – GLP-1, GIP, and glucagon receptors. This triple mechanism delivers powerful appetite suppression, enhanced fat burning, and improved blood sugar control all in one product. Whether your goal is obesity management or type 2 diabetes support, RT5 offers a comprehensive solution. Each 5 mg vial provides precise dosing for research or personal protocols.

Key Benefits:

Triple-receptor action for superior results

Reduces hunger and increases feelings of fullness

Boosts fat burning through glucagon activation

Helps stabilize blood sugar for diabetes support

Note: This is a research/cosmetic raw material peptide powder. Safe and discreet packaging provided.

For Suppliers / Wholesalers

Retatrutide (RT5) is the newest breakthrough in the peptide market, targeting the rapidly growing demand for advanced obesity and diabetes management solutions. As a triple GLP-1/GIP/glucagon receptor agonist, it offers superior efficacy compared to single or dual-agonist alternatives. Our product delivers 99%+ purity, CAS 2381089-83-2, in a 5 mg/vial format, at just $61/vial.

Why choose us?

First-mover advantage – stock the latest triple-agonist peptide

High demand for obesity and type 2 diabetes solutions

Stable inventory, from small trials to bulk exports

Complete COA available upon request

Ideal for research institutions and distributors

What Is Retatrutide ?

Retatrutide is a next-generation peptide that represents the cutting edge of metabolic research. Unlike older peptides that target only one or two receptor pathways, Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously. This triple mechanism makes it unique. GLP-1 and GIP work together to suppress appetite and improve insulin sensitivity, while glucagon activation directly increases energy expenditure and fat burning. This combination makes Retatrutide effective for both obesity and type 2 diabetes management.

Why Choose Retatrutide?
Triple-action power. Most weight loss peptides target one or two receptors. Retatrutide targets three. This means stronger appetite suppression, better blood sugar control, and most importantly – direct fat burning through glucagon activation. You are not just eating less; your body is actively burning more energy.
Designed for obesity and diabetes. Retatrutide was specifically developed to address both conditions at the same time. It helps reduce body weight while also improving blood sugar stability, making it a comprehensive solution for metabolic health.
Next-generation advantage. As one of the newest peptides in the market, Retatrutide offers something different from the crowded field of GLP-1 only products. For customers looking for the latest and most effective option, RT5 delivers.
Precision dosing. The 5 mg per vial format allows for accurate protocol customization, whether you are conducting research or following a personal weight management plan.
Proven and promising. Early clinical studies on Retatrutide have shown impressive results for both weight loss and glycemic control, positioning it as a potential leader in the next wave of metabolic peptides.